Outcome of chronic lymphocytic leukemia patients who switched from either ibrutinib or idelalisib to alternate kinase inhibitor: A retrospective study of the French Innovative Leukemia Organization (FILO)
Godet, Sophie, Protin, Caroline, Dupuis, Jehan, Dartigeas, Caroline, Bastie, Jean-Noël, Herbaux, Charles, Leblond, Véronique, de Guibert, Sophie, Ghez, David, Brion, Annie, Ysebaert, Loïc, Delmer, AlaLanguage:
english
Journal:
American Journal of Hematology
DOI:
10.1002/ajh.24981
Date:
November, 2017
File:
PDF, 722 KB
english, 2017